Journal of the National Cancer Institute

Publication Venue For
- Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors.. 115:578-585. 2023
- Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment.. 114:753-760. 2022
- Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer.. 114:600-608. 2022
- Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.. 114:592-599. 2022
- Next Step for Global Adolescent and Young Adult Oncology: A Core Patient-Centered Outcome Set.. 114:496-502. 2022
- Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors.. 112:720-727. 2020
- Exercise Affects Tumor Growth and Drug Response in a Mouse Model of Breast Cancer. 107. 2015
- Erratum. 106:dju096-dju096. 2014
- Helping patients decide: ten steps to better risk communication.. 103:1436-1443. 2011
- Erratum: Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy (Journal of the National Cancer Institute (2011) 103:12 (910-913)). 103:1278-. 2011
- Response. 103:1901-1903. 2010
- Why Would Hyperthermia Work?. 102:80-80. 2010
- Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (Journal of the National Cancer Institute (2007) 99 (1232-1239)). 100:685. 2008
- Toward a systems engineering approach to cancer drug delivery.. 99:983-985. 2007
- Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer.. 95:581-587. 2003
- Do patients participating in clinical trials want to know study results?. 95:491-492. 2003
- Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.. 95:308-315. 2003
- Etiology of the mutational spectrum of ras genes in human carcinomas.. 94:1516-1517. 2002
- An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.. 94:1091-1099. 2002
- Re: Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer - Response. 94:777-777. 2002
- Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.. 94:430-437. 2002
- Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.. 94:284-290. 2002
- Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.. 94:32-38. 2002
- Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta.. 94:50-60. 2002
- Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer.. 93:1886-1888. 2001
- Gamma-radiation sensitivity and risk of glioma.. 93:1553-1557. 2001
- Transcriptional response to hypoxia in human tumors.. 93:1337-1343. 2001
- Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.. 93:1204-1214. 2001
- Cyclin D1 polymorphism and increased risk of colorectal cancer at young age.. 93:1106-1108. 2001
- Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat.. 93:990-998. 2001
- Viruses as therapeutic agents against malignant disease of the central nervous system.. 93:889-890. 2001
- Detecting colorectal cancer in stool with the use of multiple genetic targets.. 93:858-865. 2001
- Guidelines 2000 for colon and rectal cancer surgery.. 93:583-596. 2001
- Cancer risk in men exposed in utero to diethylstilbestrol.. 93:545-551. 2001
- Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.. 92:1805-1811. 2000
- Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.. 92:1764-1772. 2000
- Predicting the cumulative risk of false-positive mammograms.. 92:1657-1666. 2000
- Re: initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.. 92:1445-1446. 2000
- Optimizing dendritic cell function by genetic modification.. 92:1198-1199. 2000
- Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.. 92:937-939. 2000
- DNA repair: a double-edged sword.. 92:440-441. 2000
- Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.. 92:143-147. 2000
- Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.. 90:1824-1829. 1998
- Prognostic applications of the epidermal growth factor receptor and its ligand, transforming growth factor-alpha.. 90:799-801. 1998
- Prediagnostic serum vitamin D and breast cancer.. 90:461-463. 1998
- Protein expression and functional analysis of the FHIT gene in human tumor cells.. 90:426-432. 1998
- Re: Researchers make slow headway in managing dry mouth.. 89:1894-1895. 1997
- Response. 89:1727-1727. 1997
- Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.. 89:955-959. 1997
- Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.. 89:932-938. 1997
- Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.. 89:227-238. 1997
- Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.. 88:1210-1215. 1996
- Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.. 88:908-917. 1996
- Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.. 88:661-667. 1996
- Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.. 88:552-554. 1996
- Are time or intensity factors important to the definition of metastases of unknown origin?. 88:462-463. 1996
- Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma.. 87:1870-1875. 1995
- Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.. 87:756-761. 1995
- p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis.. 86:1871-1873. 1994
- Re: Breast cancer mortality among female electrical workers in the United States.. 86:1801-1802. 1994
- Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. 86:1027. 1994
- Re: Toxicity of intrathecal melphalan.. 86:870-871. 1994
- Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.. 86:608-613. 1994
- Validation of a breast cancer risk assessment model in women with a positive family history.. 86:620-625. 1994
- Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.. 86:372-378. 1994
- Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course.. 86:51-53. 1994
- Erratum: Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme (Journal of the National Cancer Institute (1992) 84 (1926-1931)). 86:1027. 1994
- Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.. 85:1994-2003. 1993
- Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.. 85:1839-1844. 1993
- Elevation of multiple serum markers in patients with stage I ovarian cancer.. 85:1748-1751. 1993
- Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.. 85:1499-1507. 1993
- Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.. 85:1513-1519. 1993
- Silicone controversy: a survey of women with breast cancer and silicone implants.. 85:1407-1411. 1993
- Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.. 85:1159-1164. 1993
- Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma.. 85:1080-1085. 1993
- Intersociety Council on Radiation Oncology essay on the introduction of new medical treatments into practice.. 85:951-957. 1993
- Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy.. 85:488-493. 1993
- Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B.. 85:316-320. 1993
- Response. 85:1252-1253. 1993
- Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.. 84:1926-1931. 1992
- Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.. 84:1793-1798. 1992
- Environmental tobacco smoke and lung cancer risk in nonsmoking women.. 84:1417-1422. 1992
- Antineoplastic drug screening.. 84:1288-1290. 1992
- Malignant transformation of ovarian epithelium.. 84:556-558. 1992
- 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.. 84:235-241. 1992
- Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.. 82:825-835. 1990
- Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.. 81:1840-1842. 1989
- Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.. 81:1735-1738. 1989
- Genetic changes in human adrenocortical carcinomas.. 81:518-523. 1989
- Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.. 81:524-527. 1989
- Regression models in clinical studies: determining relationships between predictors and response.. 80:1198-1202. 1988
- Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.. 80:1016-1026. 1988
- Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.. 79:123-130. 1987
- Statistically adjusted estimates of geographic mortality profiles.. 78:805-815. 1987
- Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases.. 77:1013-1021. 1986
- Comparison of temporal changes in U.S. and Swedish lung cancer, 1950-51 to 1981-82.. 77:665-675. 1986
- Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.. 75:703-708. 1985
- Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.. 75:709-715. 1985
- Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.. 75:717-724. 1985
- Murine in vitro antigenic modification of tumor cells: effect on susceptibility to natural cell-mediated cytotoxicity.. 74:699-704. 1985
- Cloning efficiency of cultured human tumor cell lines measured with the use of a Coulter particle counter.. 73:555-563. 1984
- Hepatic prolactin binding in female Sprague-Dawley rats fed a diet high in corn oil.. 73:531-536. 1984
- Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies.. 71:11-17. 1983
- Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.. 70:1005-1010. 1983
- Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.. 70:69-74. 1983
- Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.. 69:509-515. 1982
- Environmental factors in the etiology of rhabdomyosarcoma in childhood.. 68:107-113. 1982
- Biology of hepatocellular neoplasia in the mouse. I. Histogenesis of safrole-induced hepatocellular carcinoma.. 67:365-376. 1981
- Biology of hepatocellular neoplasia in the mouse. II. Sequential enzyme histochemical analysis of BALB/c mouse liver during safrole-induced carcinogenesis.. 67:377-392. 1981
- Biology of hepatocellular neoplasia in the mouse. III. Electron microscopy of safrole-induced hepatocellular adenomas and hepatocellular carcinomas.. 67:393-405. 1981
- In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.. 67:107-115. 1981
- In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.. 67:117-122. 1981
- In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.. 67:123-130. 1981
- In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.. 66:529-533. 1981
- Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.. 65:829-834. 1980
- Detection and partial characterization of human thymus-leukemia antigens.. 65:691-701. 1980
- Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.. 64:547-553. 1980
- A two-disease model of female breast cancer: mortality in 1969 among white females in the United States.. 64:9-16. 1980
- Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans.. 63:1273-1278. 1979
- Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy.. 63:615-622. 1979
- Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.. 63:423-426. 1979
- Do macrophages destroy nascent tumors?. 62:1341-1345. 1979
- Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens.. 62:293-298. 1979
- Solubilization and partial isolation of human melanoma tumor-associated antigens.. 61:61-67. 1978
- Abnormal monocyte chemotaxis in patients with breast cancer: evidence for a tumor-mediated effect.. 60:737-740. 1978
- Prognostic factors in the initial response to therapy by patients with advanced breast cancer.. 60:731-736. 1978
- Detection of metastatic tumors in nude mice: brief communication.. 60:715-716. 1978
- Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.. 60:141-152. 1978
- Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.. 60:131-139. 1978
- Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay.. 59:99-106. 1977
- Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens.. 58:215-221. 1977
- Organ distribution of Corynebacterium parvum labeled with iodine-125.. 58:287-294. 1977
- Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal.. 58:37-41. 1977
- Adenocarcinoma of the kidney. II. Enzyme histochemistry of renal adenocarcinomas induced in rats by N-(4'-fluoro-4-biphenylyl)acetamide.. 57:795-808. 1976
- Cellular immunity in rats with primary brain tumors: inhibition of macrophage migration by soluble extracts of avian sarcoma virus-induced tumors.. 56:1119-1123. 1976
- Sequential adsorption analysis of antibodies to neuroectodermal cells by an indirect quantitative method.. 56:1201-1205. 1976
- Humoral antibody response and tumor transplantation resistance elicited by fetal tissues in mice.. 56:401-404. 1976
- Defective monocyte function in patients with genitourinary carcinoma.. 55:1047-1054. 1975
- R-type virus-like particles in avian sarcoma virus-induced rat central nervous system tumors.. 54:1479-1482. 1975
- Response of chick-embryo kidney cells in vitro to two avian tumor viruses.. 53:711-718. 1974
- Human leukemia antigens: partial isolation and characterization.. 52:1445-1453. 1974
- Brief communication: melanoma-specific antibodies produced in monkeys by immunization with human melanoma cell lines.. 50:1065-1068. 1973
- HL-A antigenic loss in malignant transformation.. 46:577-584. 1971
- Cerebral physiology in dogs after brain-tumor induction with Schmidt-Ruppin Rous sarcoma virus: experiences with radioiodinated normal and antiviral immunoglobulin G.. 43:565-573. 1969
- Response: Re: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis [2]. 99:1344. 2007
- Body dimension differences in men with or without prostate cancer.. 84:1363-1364. 1992
- Refusal of cancer treatment in testicular cancer patients.. 81:1587-1588. 1989

Publication Venue For